STOK — Stoke Therapeutics, Inc. stock price, charts and financials

QT60Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. (NASDAQ: STOK) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
31.67
+2.11+7.14%
OverviewShort InterestFilings
STOKQT60Stoke Therapeutics, Inc.·NASDAQ
31.67+7.14%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 20268-KCurrent report
Aug 03, 20268-KCurrent report
Aug 03, 202610-QQuarterly report
Aug 03, 2026S-8Registration of employee benefit securities
Aug 03, 2026424B5Prospectus
Jul 17, 20263Initial statement of beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 30, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
Jun 03, 20264Statement of changes in beneficial ownership
May 18, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 389
Page
▼
/ 16